Clinical Trials in Los Angeles

Showing 5621-5640 of 16,901 trials

A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children

NCT04261985

To pilot a stand-alone mobile phone intervention with Latino caregivers of 2- to 5-year olds, using a prospective control group design, to assess feasibility and preliminary effect sizes on children's BMI changes (primary outcome) and dietary and physical activity changes (secondary outcomes) at 6 months post-baseline, in preparation for a larger randomized trial to evaluate the intervention's efficacy.

Childhood ObesityParentingMobile Phone Use

University of California, Los Angeles59 participantsStarted Jun 2020

Los Angeles, California, United States

WITHDRAWNPhase 1< 1 mile

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

NCT05867056

IMC-I109V is an immune-mobilizing monoclonal T cell receptor (TCR) against viruses (ImmTAV®), a new class of bispecific protein therapeutics designed for the treatment of chronic hepatitis B virus (HBV) infection (CHB). This is the first in-human study of IMC-I109V in persons with CHB.

Hepatitis B, Chronic

Immunocore LtdStarted Aug 2020

Los Angeles, California, United States • Cleveland, Ohio, United States • Fitzroy, Australia +12 more locations

A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Find Trials by Condition in Los Angeles

Treatment of Interproximal Cavities on Primary Molar Teeth With Silver Diamine Fluoride

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Atrasentan in Patients With IgA Nephropathy

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

MyoVista Measurements in Patients With Atherosclerosis and CAD

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.

Determinants of the Effectiveness of Robot-assisted Hand Movement Training

A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Lay-Delivered Behavioral Activation in Senior Centers

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)